Patients with multiple sclerosis who initiated ocrelizumab therapy earlier and continued long-term treatment sustained lower annualized relapse rates ... read more
Long-Term Ocrelizumab Reduces Relapse Rate and Disability Progression in MS
Long-Term Ocrelizumab Reduces Relapse Rate and Disability Progression in MS